Waddington J L, Gamble S J
Eur J Pharmacol. 1980 Oct 31;67(4):363-9. doi: 10.1016/0014-2999(80)90177-6.
Rats were treated chronically with haloperidol (1.5 mg/kg per day in drinking water) for up to 9 months. At 1 week, 3.5 months and 9 months after commencing treatment, spontaneous activity in separate groups was depressed by 30-40%. Apomorphine stereotypy was also attenuated at 9 months. Following a 7-10 day withdrawal period after 9 months of treatment, both measures were elevated. Enhancement of spontaneous activity appeared to be at least in part characterised by a deficit in psychomotor habituation to the test apparatus. DA receptor blockade during haloperidol treatment for a substantial proportion of a rat's adult life was found to be an enduring effect, paralleling its antipsychotic action. Developing neurochemical supersensitivity was only manifested behaviourally after withdrawal of neuroleptic. The implications of such findings for the pathophysiology of schizophrenia and tardive dyskinesia and for the functional significance of dopamine receptor heterogeneity are discussed.
大鼠长期接受氟哌啶醇治疗(饮用水中剂量为每天1.5毫克/千克),长达9个月。在开始治疗后的1周、3.5个月和9个月时,不同组的自发活动减少了30%-40%。在9个月时,阿扑吗啡刻板行为也有所减轻。在9个月的治疗后经过7-10天的撤药期,这两项指标均有所升高。自发活动的增强似乎至少部分表现为对测试仪器的精神运动习惯化缺陷。在大鼠成年期的相当一部分时间内进行氟哌啶醇治疗期间的多巴胺受体阻断被发现是一种持久效应,与其抗精神病作用相似。神经化学超敏反应仅在停用抗精神病药物后才在行为上表现出来。讨论了这些发现对精神分裂症和迟发性运动障碍的病理生理学以及多巴胺受体异质性的功能意义的影响。